Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Sicre de Fontbrune, Flore  [Clear All Filters]
2024
Boussen I, Salmona M, de Fontbrune FSicre, Xhaard A, De Castro N, Delaugerre C, Chaix M-L, Molina J-M. Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection. Antivir Ther. 2024;29(1):13596535221097495.
de Latour RPeffault, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, et al. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024;390(11):994-1008.
2023
Hakkarainen M, Kaaja I, Douglas SPM, Vulliamy TJ, Dokal I, Soulier J, Larcher L, de Latour RPeffault, Leblanc TM, de Fontbrune FSicre, et al. The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia. Blood. 2023.
Gurnari C, Robin M, Godley LA, Drozd-Sokołowska J, Włodarski MW, Raj K, Onida F, Worel N, Ciceri F, Carbacioglu S, et al. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. Lancet Haematol. 2023.
2022
Xhaard A, Villate A, Hamane S, Michonneau D, Menotti J, Robin M, de Fontbrune FSicre, Dhedin N, de la Tour RPeffault, Socié G, et al. A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients. Bone Marrow Transplant. 2022.
2021
Rotulo GA, Plat G, Beaupain B, Blanche S, Moushous D, de Fontbrune FSicre, Leblanc T, Renard C, Barlogis V, Vigue M-G, et al. Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia: a French Severe Chronic Neutropenia Registry study. Br J Haematol. 2021.
Longval T, Galimard J-E, Leprêtre A-C, Suarez F, Amiranoff D, Cazaux M, Kaphan E, Michonneau D, Dhedin N, Coman T, et al. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study. Br J Haematol. 2021.
2019
de Latour RPeffault, Chevret S, Ruggeri ALisa, Suarez F, Souchet L, Michonneau D, de Fontbrune FSicre, Coman T, Dhedin N, Rubio MThérèse, et al. Romiplostim in Patients undergoing Hematopoietic Stem Cell Transplantation: Results of a Phase I/II multicenter Trial. Blood. 2019.
2015
O'Meara A, Boukouaci W, Robin M, Xhaard A, Fortier C, Marzais F, de Fontbrune FSicre, de Latour RPeffault, Charron D, Socié G, et al. GLCCI1 and GR genetic diversity and response to glucocorticoid-based treatment of graft-versus-host disease. Biol Blood Marrow Transplant. 2015.
de Fontbrune FSicre, de Latour RPeffault. Paroxysmal Nocturnal Hemoglobinuria and Hematopoietic Stem Cell Transplantation: better results in 2015?. Leuk Lymphoma. 2015:1-5.
2014
Itzykson R, Robin M, Moins-Teisserenc H, Delord M, Busson M, Xhaard A, de Fontbrune FSicre, de Latour RPeffault, Toubert A, Socié G. Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. Haematologica. 2014.